Representative Pete Sessions (R-Texas) recently sold shares of Danaher Corporation NYSE: DHR. In a filing disclosed on June 21st, the Representative disclosed that they had sold between $50,001 and $100,000 in Danaher stock on June 12th. The trade occurred in the Representative's "TRUST ONE" account.
Representative Pete Sessions also recently made the following trade(s):
- Sold $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 6/12/2025.
Danaher Stock Performance
DHR stock traded down $4.81 during midday trading on Friday, hitting $189.98. 4,239,169 shares of the company traded hands, compared to its average volume of 3,523,488. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The business has a 50 day simple moving average of $196.13 and a 200-day simple moving average of $205.03. The stock has a market capitalization of $135.96 billion, a price-to-earnings ratio of 36.89, a price-to-earnings-growth ratio of 2.67 and a beta of 0.77.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. As a group, equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.67%. Danaher's dividend payout ratio (DPR) is presently 24.85%.
Wall Street Analysts Forecast Growth
DHR has been the topic of several research analyst reports. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Wells Fargo & Company reduced their target price on Danaher from $240.00 to $210.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 23rd. Finally, Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $248.48.
Get Our Latest Stock Report on DHR
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Heck Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter worth about $27,000. GHP Investment Advisors Inc. increased its position in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC increased its position in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Hurley Capital LLC acquired a new stake in Danaher in the fourth quarter worth about $34,000. Finally, Rialto Wealth Management LLC acquired a new stake in Danaher in the fourth quarter worth about $34,000. 79.05% of the stock is owned by institutional investors.
Insider Transactions at Danaher
In other news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president directly owned 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.
About Representative Sessions
Pete Sessions (Republican Party) is a member of the U.S. House, representing Texas' 17th Congressional District. He assumed office on January 3, 2021. His current term ends on January 3, 2027.
Sessions (Republican Party) ran for re-election to the U.S. House to represent Texas' 17th Congressional District. He won in the general election on November 5, 2024.
On October 20, 2023, Sessions announced he was running to replace Kevin McCarthy (R) as speaker of the U.S. House in the 118th Congress. Sessions lost the first round of nomination voting on October 24, 2023.
Pete Sessions was born and lives in Waco, Texas. Sessions earned a B.S. from Southwestern University in 1978. Sessions' career experience includes working as an executive with AT&T.
About Danaher
(
Get Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
